195 related articles for article (PubMed ID: 11510889)
1. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.
Levillain O; Marescau B; Possemiers I; Al Banchaabouchi M; De Deyn PP
Pflugers Arch; 2001 Jul; 442(4):558-69. PubMed ID: 11510889
[TBL] [Abstract][Full Text] [Related]
2. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
Levillain O; Marescau B; de Deyn PP
Kidney Int; 1995 Feb; 47(2):464-72. PubMed ID: 7536856
[TBL] [Abstract][Full Text] [Related]
3. Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice.
Al Banchaabouchi M; Marescau B; Van Marck E; D'hooge R; De Deyn PP
Metabolism; 2001 Dec; 50(12):1418-25. PubMed ID: 11735086
[TBL] [Abstract][Full Text] [Related]
4. Renal handling of guanidino compounds in rat and rabbit.
Levillain O; Marescau B; De Deyn PP
J Physiol; 1997 Mar; 499 ( Pt 2)(Pt 2):561-70. PubMed ID: 9080382
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and histopathological changes in nephrectomized mice.
Al Banchaabouchi M; Marescau B; D'Hooge R; Van Marck E; Van Daele A; Levillain O; De Deyn PP
Metabolism; 1998 Mar; 47(3):355-61. PubMed ID: 9500577
[TBL] [Abstract][Full Text] [Related]
6. Dehydration modifies guanidino compound concentrations in the different zones of the rat kidney.
Levillain O; Marescau B; Possemiers I; De Deyn P
Pflugers Arch; 2002 May; 444(1-2):143-52. PubMed ID: 11976926
[TBL] [Abstract][Full Text] [Related]
7. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency.
Marescau B; Nagels G; Possemiers I; De Broe ME; Becaus I; Billiouw JM; Lornoy W; De Deyn PP
Metabolism; 1997 Sep; 46(9):1024-31. PubMed ID: 9284891
[TBL] [Abstract][Full Text] [Related]
8. [Guanidino compounds and aliphatic monoamines in acute and chronic renal failure].
Suzuki Y
Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1077-85. PubMed ID: 1289608
[TBL] [Abstract][Full Text] [Related]
9. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of methylguanidine and changes in guanidino compound levels in plasma, urine, and kidneys of furosemide-treated rats.
Levillain O; Marescau B; Possemiers I; De Deyn PP
Metabolism; 2008 Jun; 57(6):802-10. PubMed ID: 18502263
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of arginine by the isolated perfused rat kidney.
Perez GO; Epstein M; Rietberg B; Loutzenhiser R
Am J Physiol; 1978 Oct; 235(4):F376-80. PubMed ID: 696875
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentration and urinary excretion of guanidine derivatives in normal subjects and patients with renal failure.
Sawynok J; Dawborn JK
Clin Exp Pharmacol Physiol; 1975; 2(1):1-15. PubMed ID: 1126056
[TBL] [Abstract][Full Text] [Related]
13. [Chronic renal failure and guanidino compounds].
Kinoshita T
Yakugaku Zasshi; 1997 Nov; 117(10-11):673-80. PubMed ID: 9414581
[TBL] [Abstract][Full Text] [Related]
14. Guanidino compounds in uraemic dialysed patients.
De Deyn P; Marescau B; Lornoy W; Becaus I; Lowenthal A
Clin Chim Acta; 1986 Jun; 157(2):143-50. PubMed ID: 3719996
[TBL] [Abstract][Full Text] [Related]
15. Guanidino compound levels in brain regions of non-dialyzed uremic patients.
De Deyn PP; Marescau B; D'Hooge R; Possemiers I; Nagler J; Mahler C
Neurochem Int; 1995 Sep; 27(3):227-37. PubMed ID: 8520461
[TBL] [Abstract][Full Text] [Related]
16. Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy.
Marescau B; De Deyn PP; Lowenthal A; Qureshi IA; Antonozzi I; Bachmann C; Cederbaum SD; Cerone R; Chamoles N; Colombo JP
Pediatr Res; 1990 Mar; 27(3):297-303. PubMed ID: 1690873
[TBL] [Abstract][Full Text] [Related]
17. Guanidino compounds after creatine supplementation in renal failure patients and their relation to inflammatory status.
Taes YE; Marescau B; De Vriese A; De Deyn PP; Schepers E; Vanholder R; Delanghe JR
Nephrol Dial Transplant; 2008 Apr; 23(4):1330-5. PubMed ID: 18048424
[TBL] [Abstract][Full Text] [Related]
18. Guanidino compounds and hemodialysis.
Ochiai Y; Abe S; Yamada T; Tada K; Kosaka F
Adv Exp Med Biol; 1982; 153():459-64. PubMed ID: 7164919
[No Abstract] [Full Text] [Related]
19. Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans.
Derave W; Marescau B; Vanden Eede E; Eijnde BO; De Deyn PP; Hespel P
J Appl Physiol (1985); 2004 Sep; 97(3):852-7. PubMed ID: 15107411
[TBL] [Abstract][Full Text] [Related]
20. Metabolic pathway of guanidino compounds in chronic renal failure.
Mikami H; Orita Y; Ando A; Fujii M; Kikuchi T; Yoshihara K; Okada A; Abe H
Adv Exp Med Biol; 1982; 153():449-58. PubMed ID: 7164918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
